In Heart failure Heart failure means your heart is weak and cannot pump enough blood to your lungs and the rest of your body. The most common symptoms are breathlessness, tiredness, and swelling in your legs, ankles, abdomen and other parts of your body. Levosimed 12.5mg Injection makes it easier for your heart to pump blood around your body and is therefore an effective treatment for heart failure. It is given as an injection by a doctor or nurse and should not be self-administered. This medicine will help relieve your symptoms, making you feel better and more energetic. You should make appropriate lifestyle changes (such as eating healthily and keeping active) to help this medicine be effective. Take it regularly and keep taking it even if you feel better.
It is not known whether it is safe to consume alcohol with Levosimed 12.5mg Injection. Please consult your doctor.
Information regarding the use of Levosimed 12.5mg Injection during pregnancy is not available. Please consult your doctor.
Information regarding the use of Levosimed 12.5mg Injection during breastfeeding is not available. Please consult your doctor.
Levosimed 12.5mg Injection does not usually affect your ability to drive.
Levosimed 12.5mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Levosimed 12.5mg Injection may be needed. Please consult your doctor. Use of Levosimed 12.5mg Injection is not recommended in patients with severe kidney disease.
Levosimed 12.5mg Injection should be used with caution in patients with severe liver disease. Dose adjustment of Levosimed 12.5mg Injection may be needed. Please consult your doctor. No dose adjustment is recommended in patients with mild to moderate liver disease.
If you miss a dose of Levosimed 12.5mg Injection, please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zydus Cadila || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Neon Laboratories Ltd || ₹14.5/tablet (25% cheaper)